On the public citation graph
Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice
0 signed · 811 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archinte.148.11.2477openalex-snapshot
Treatment of Toxoplasmic Encephalitis With Intravenous Clindamycin
inferredcites →https://doi.org/10.1001/archopht.1962.00960020712004openalex-snapshot
Treatment of Toxoplasmosis Uveitis
inferredcites →https://doi.org/10.1001/archopht.1964.00970010074010openalex-snapshot
Toxoplasmic Retinochoroiditis: A Double Blind Therapeutic Study
inferredcites →https://doi.org/10.1001/archopht.1964.00970010899023openalex-snapshot
THERAPY OF TOXOPLASMIC RETINOCHOROIDITIS
inferredcites →https://doi.org/10.1001/archopht.1964.00970020084019openalex-snapshot
Experimental Use of Folinic Acid in the Treatment of Toxoplasmosis With Pyrimethamine
inferredcites →https://doi.org/10.1001/archopht.1974.01010010252017openalex-snapshot
Clindamycin Effects on Experimental Ocular Toxoplasmosis in the Rabbit
inferredcites →https://doi.org/10.1001/jama.1984.03350070031018openalex-snapshot
Toxoplasmic Encephalitis in Patients With Acquired Immune Deficiency Syndrome
inferredcites →https://doi.org/10.1002/14651858.cd001684openalex-snapshot
Treatments for toxoplasmosis in pregnancy
inferredcites →https://doi.org/10.1002/14651858.cd002218.pub2openalex-snapshot
Antibiotics versus no treatment for toxoplasma retinochoroiditis
inferredcites →https://doi.org/10.1002/14651858.cd005420openalex-snapshot
Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)
inferredcites →https://doi.org/10.1002/14651858.cd005420.pub2openalex-snapshot
Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)
inferredcites →https://doi.org/10.1002/14651858.cd007417.pub2openalex-snapshot
Corticosteroids as adjuvant therapy for ocular toxoplasmosis
inferredcites →https://doi.org/10.1002/14651858.cd007417.pub3openalex-snapshot
Corticosteroids as adjuvant therapy for ocular toxoplasmosis
inferredcites →https://doi.org/10.1007/bf01964427openalex-snapshot
Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses andPneumocystis carinii pneumonia in HIV-infected patients
inferredcites →https://doi.org/10.1007/bf01964458openalex-snapshot
A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine
inferredcites →https://doi.org/10.1007/bf01964460openalex-snapshot
Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis
inferredcites →https://doi.org/10.1007/bf01967063openalex-snapshot
Cotrimoxazole therapy ofToxoplasma gondii encephalitis in AIDS patients
inferredcites →https://doi.org/10.1007/bf02000407openalex-snapshot
Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS
inferredcites →https://doi.org/10.1007/bf02230867openalex-snapshot
Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS
inferredcites →https://doi.org/10.1007/s00417-010-1379-9openalex-snapshot
Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?
inferredcites →https://doi.org/10.1007/s00436-013-3488-yopenalex-snapshot
Preventive effect of pidotimod on reactivated toxoplasmosis in mice
inferredcites →https://doi.org/10.1007/s00436-017-5478-yopenalex-snapshot
Toxoplasma gondii and schizophrenia: a review of published RCTs
inferredcites →https://doi.org/10.1007/s004360050185openalex-snapshot
Effect of immunosuppressive drug regimens on acute and chronic murine toxoplasmosis
inferredcites →https://doi.org/10.1007/s004360050258openalex-snapshot
Parasitemia and parasitic loads in acute infection and after anti-gamma-interferon treatment in a toxoplasmic mouse model
inferredcites →https://doi.org/10.1007/s10096-008-0612-5openalex-snapshot
Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy
inferredcites →https://doi.org/10.1007/s10096-013-1879-8openalex-snapshot
Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review
inferredcites →https://doi.org/10.1007/s100960050436openalex-snapshot
Thrice-Weekly Sulfadiazine-Pyrimethamine for Maintenance Therapy of Toxoplasmic Encephalitis in HIV-Infected Patients
inferredcites →https://doi.org/10.1007/s10792-012-9634-1openalex-snapshot
Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial
inferredcites →https://doi.org/10.1007/s12185-013-1379-8openalex-snapshot
Acute exacerbation of Toxoplasma gondii infection after hematopoietic stem cell transplantation: five case reports among 279 recipients
inferredcites →https://doi.org/10.1016/0002-9343(87)90151-3openalex-snapshot
Assessment of therapy for toxoplasma encephalitis
inferredcites →https://doi.org/10.1016/0002-9343(88)90014-9openalex-snapshot
Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome
inferredcites →https://doi.org/10.1016/0002-9343(89)90378-1openalex-snapshot
Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome
inferredcites →https://doi.org/10.1016/0002-9394(82)90541-4openalex-snapshot
Minocycline in Experimental Ocular Toxoplasmosis in the Rabbit
inferredcites →https://doi.org/10.1016/0002-9394(83)90378-1openalex-snapshot
Clindamycin in the Treatment of Toxoplasmic Retinochoroiditis
inferredcites →https://doi.org/10.1016/0140-6736(91)91996-8openalex-snapshot
Guillain-Barré syndrome as presenting manifestation of visceral leishmaniasis
inferredcites →https://doi.org/10.1016/0140-6736(91)91997-9openalex-snapshot
Clindamycin for toxoplasma encephalitis in AIDS
inferredcites →https://doi.org/10.1016/j.actatropica.2013.05.006openalex-snapshot
Meta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patients
inferredcites →https://doi.org/10.1016/j.ajo.2013.12.022openalex-snapshot
Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrences of Toxoplasma Gondii Retinochoroiditis: Randomized Controlled Clinical Trial
inferredcites →https://doi.org/10.1016/j.ajo.2015.02.015openalex-snapshot
Ocular Involvement Following Postnatally Acquired Toxoplasma gondii Infection in Southern Brazil: A 28-Year Experience
inferredcites →https://doi.org/10.1016/j.ajo.2015.02.017openalex-snapshot
Ocular Involvement Following an Epidemic of Toxoplasma gondii Infection in Santa Isabel do Ivaí, Brazil
inferredcites →https://doi.org/10.1016/j.ajo.2016.08.003openalex-snapshot
Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up
inferredcites →https://doi.org/10.1016/j.ajog.2004.07.031openalex-snapshot
Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening
inferredcites →https://doi.org/10.1016/j.ajog.2018.05.031openalex-snapshot
Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial
inferredcites →https://doi.org/10.1016/j.cmi.2014.09.018openalex-snapshot
Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program
inferredcites →https://doi.org/10.1016/j.cmi.2018.01.029openalex-snapshot
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction)
inferredcites →https://doi.org/10.1016/j.exppara.2005.12.006openalex-snapshot
Toxoplasma gondii: In vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1′-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine
inferredcites →https://doi.org/10.1016/j.ijantimicag.2004.09.015openalex-snapshot
Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis
inferredcites →https://doi.org/10.1016/j.ijid.2009.11.015openalex-snapshot
Treatment of toxoplasmic lymphadenitis with co-trimoxazole: double-blind, randomized clinical trial
inferredcites →https://doi.org/10.1016/j.jcpa.2017.04.003openalex-snapshot
Ovine Toxoplasmosis: A New Look at its Pathogenesis
inferredcites →https://doi.org/10.1016/j.jinf.2017.05.018openalex-snapshot
Incidence, presentation and outcome of toxoplasmosis in HIV infected in the combination antiretroviral therapy era
inferredcites →https://doi.org/10.1016/j.joco.2016.10.002openalex-snapshot
A prospective randomized trial of azithromycin versus trimethoprim/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis
inferredcites →https://doi.org/10.1016/j.micinf.2007.09.004openalex-snapshot
Control of IFN-γ-mediated host resistance to intracellular pathogens by immunity-related GTPases (p47 GTPases)
inferredcites →https://doi.org/10.1016/j.nrl.2015.06.016openalex-snapshot
Lesiones cerebrales en trasplante renal de larga evolución, ¿linfoma cerebral primario vs. toxoplasmosis cerebral?
inferredcites →https://doi.org/10.1016/j.nrleng.2015.06.016openalex-snapshot
Brain lesions in a long-term kidney transplant recipient: Primary cerebral lymphoma or cerebral toxoplasmosis?
inferredcites →https://doi.org/10.1016/j.ophtha.2005.05.025openalex-snapshot
Prospective Randomized Trial of Trimethoprim/Sulfamethoxazole versus Pyrimethamine and Sulfadiazine in the Treatment of Ocular Toxoplasmosis
inferredcites →https://doi.org/10.1016/j.ophtha.2007.06.022openalex-snapshot
Longitudinal Study of New Eye Lesions in Treated Congenital Toxoplasmosis
inferredcites →https://doi.org/10.1016/j.ophtha.2010.01.028openalex-snapshot
Intravitreal Clindamycin and Dexamethasone for Zone 1 Toxoplasmic Retinochoroiditis at Twenty-four Months
inferredcites →https://doi.org/10.1016/j.ophtha.2010.04.020openalex-snapshot
Randomized Trial of Intravitreal Clindamycin and Dexamethasone versus Pyrimethamine, Sulfadiazine, and Prednisolone in Treatment of Ocular Toxoplasmosis
inferredcites →https://doi.org/10.1016/j.ophtha.2012.07.061openalex-snapshot
Interventions for Toxoplasma Retinochoroiditis
inferredcites →https://doi.org/10.1016/j.preteyeres.2013.12.005openalex-snapshot
Ocular toxoplasmosis past, present and new aspects of an old disease
inferredcites →https://doi.org/10.1016/j.pt.2016.10.007openalex-snapshot
Lifelong Persistence of Toxoplasma Cysts: A Questionable Dogma?
inferredcites →https://doi.org/10.1016/j.pt.2017.02.001openalex-snapshot
Lifelong Persistence of Toxoplasma Cysts: A Questionable Dogma?
inferredcites →https://doi.org/10.1016/s0002-9378(99)70311-xopenalex-snapshot
Prenatal diagnosis of congenital toxoplasmosis: A multicenter evaluation of different diagnostic parameters
inferredcites →https://doi.org/10.1016/s0002-9394(02)01526-xopenalex-snapshot
An update on current practices in the management of ocular toxoplasmosis
inferredcites →https://doi.org/10.1016/s0002-9394(02)01527-1openalex-snapshot
The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis
inferredcites →https://doi.org/10.1016/s0002-9394(14)74456-3openalex-snapshot
Therapy for Ocular Toxoplasmosis
inferredcites →https://doi.org/10.1016/s0140-6736(07)60072-5openalex-snapshot
Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data
inferredcites →https://doi.org/10.1016/s0140-6736(86)90785-3openalex-snapshot
RESULTS OF 20-YEAR FOLLOW-UP OF CONGENITAL TOXOPLASMOSIS
inferredcites →https://doi.org/10.1016/s0140-6736(94)92298-5openalex-snapshot
Toxoplasmosis in pregnancy
inferredcites →https://doi.org/10.1016/s0140-6736(98)08220-8openalex-snapshot
Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling
inferredcites →https://doi.org/10.1016/s0147-9571(96)00038-0openalex-snapshot
Toxoplasmosis: Comparative species susceptibility and host immune response
inferredcites →https://doi.org/10.1016/s0161-6420(03)00083-6openalex-snapshot
Antibiotics for toxoplasmic retinochoroiditis
inferredcites →https://doi.org/10.1016/s0161-6420(80)35268-8openalex-snapshot
Treatment of Ocular Toxoplasmosis with Clindamycin and Sulfadiazine
inferredcites →https://doi.org/10.1016/s0161-6420(99)90021-0openalex-snapshot
Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients11The authors have no financial interest in atovaquone or Burroughs Wellcome Co.
inferredcites →https://doi.org/10.1016/s0304-4017(97)00227-6openalex-snapshot
Toxoplasmosis of rats: a review, with considerations of their value as an animal model and their possible role in epidemiology
inferredcites →https://doi.org/10.1016/s0924-8579(98)00064-8openalex-snapshot
Treatment protocol determines the efficacy of clindamycin in acute murine toxoplasmosis
inferredcites →https://doi.org/10.1016/s1286-4579(00)00318-xopenalex-snapshot
Induction of tumor necrosis factor-α and inducible nitric oxide synthase fails to prevent toxoplasmic encephalitis in the absence of interferon-γ in genetically resistant BALB/c mice
inferredcites →https://doi.org/10.1016/s1470-0328(02)02325-xopenalex-snapshot
Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii
inferredcites →https://doi.org/10.1021/acs.jmedchem.6b00760openalex-snapshot
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis
inferredcites →https://doi.org/10.1021/acs.jmedchem.7b01192openalex-snapshot
Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii
inferredcites →https://doi.org/10.1021/bi048080xopenalex-snapshot
An Apolipoprotein E-Derived Peptide Mediates Uptake of Sterically Stabilized Liposomes into Brain Capillary Endothelial Cells
inferredcites →https://doi.org/10.1023/a:1006129422690openalex-snapshot
Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine
inferredcites →https://doi.org/10.1038/jp.2014.161openalex-snapshot
Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy
inferredcites →https://doi.org/10.1038/sj.bmt.1703425openalex-snapshot
Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature
inferredcites →https://doi.org/10.1051/parasite/1995023243openalex-snapshot
Modèles expérimentaux de Toxoplasmose. Applications Pharmacologiques
inferredcites →https://doi.org/10.1056/nejm198802043180502openalex-snapshot
Prenatal Management of 746 Pregnancies at Risk for Congenital Toxoplasmosis
inferredcites →https://doi.org/10.1056/nejm199212033272306openalex-snapshot
Toxoplasmosis of the Central Nervous System in the Acquired Immunodeficiency Syndrome
inferredcites →https://doi.org/10.1056/nejm199309303291403openalex-snapshot
Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency Syndrome
inferredcites →https://doi.org/10.1056/nejm199312233292604openalex-snapshot
Clinical Manifestations of AIDS in the Era of Pneumocystis Prophylaxis
inferredcites →https://doi.org/10.1056/nejm199406303302604openalex-snapshot
Neonatal Serologic Screening and Early Treatment for Congenital Toxoplasma gondii Infection
inferredcites →https://doi.org/10.1073/pnas.0608310104openalex-snapshot
Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors
inferredcites →https://doi.org/10.1073/pnas.1208069109openalex-snapshot
Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis
inferredcites →https://doi.org/10.1080/08035250500251999openalex-snapshot
Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: A cohort study in 13 European centres
inferredcites →https://doi.org/10.1080/08830180213281openalex-snapshot
THE ROLE OF CYTOKINES AND THEIR SIGNALING PATHWAYS IN THE REGULATION OF IMMUNITY TO Toxoplasma gondii
inferredcites →https://doi.org/10.1080/09273948.2017.1307420openalex-snapshot
Intravitreal Injection of Sulfamethoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis
inferredcites →https://doi.org/10.1080/09273948.2017.1359307openalex-snapshot
Comment on: “Intravitreal Injection of Sulfamethoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis”
inferredcites →https://doi.org/10.1080/10611860902718680openalex-snapshot
The role of apolipoprotein E in uptake of atovaquone into the brain in murine acute and reactivated toxoplasmosis
inferredcites →https://doi.org/10.1080/17843286.1990.11718072openalex-snapshot
A Retrospective Study About the use of Cotrimoxazole as Diagnostic Support and Treatment of Suspected Cerebral Toxoplasmosis in Aids
inferredcites →https://doi.org/10.1080/20477724.2016.1273597openalex-snapshot
Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis
inferredcites →https://doi.org/10.1080/20477724.2017.1370528openalex-snapshot
Prophylaxis of human toxoplasmosis: a systematic review
inferredcites →https://doi.org/10.1080/20477724.2017.1377974openalex-snapshot
Systematic review and meta-analysis of secondary prophylaxis for prevention of HIV-related toxoplasmic encephalitis relapse using trimethoprim-sulfamethoxazole
inferredcites →https://doi.org/10.1086/338006openalex-snapshot
Oral Infection of C57BL/6 Mice withToxoplasma gondii:A New Model of Inflammatory Bowel Disease?
inferredcites →https://doi.org/10.1086/338816openalex-snapshot
Discontinuation of Secondary Prophylaxis against Disseminated Mycobacterium avium Complex Infection and Toxoplasmic Encephalitis
inferredcites →https://doi.org/10.1086/339551openalex-snapshot
Randomized Phase II Trial of Atovaquone with Pyrimethamine or Sulfadiazine for Treatment of Toxoplasmic Encephalitis in Patients with Acquired Immunodeficiency Syndrome: ACTG 237/ANRS 039 Study
inferredcites →https://doi.org/10.1086/426447openalex-snapshot
Early Detection of Toxoplasma Infection by Molecular Monitoring of Toxoplasma gondii in Peripheral Blood Samples after Allogeneic Stem Cell Transplantation
inferredcites →https://doi.org/10.1086/501360openalex-snapshot
Outcome of Treatment for Congenital Toxoplasmosis, 1981-2004: The National Collaborative Chicago-Based, Congenital Toxoplasmosis Study
inferredcites →https://doi.org/10.1086/504872openalex-snapshot
Discontinuation of Primary and SecondaryToxoplasma gondiiProphylaxis Is Safe in HIV‐Infected Patients after Immunological Restoration with Highly Active Antiretroviral Therapy: Results of an Open, Randomized, Multicenter Clinical Trial
inferredcites →https://doi.org/10.1086/520141openalex-snapshot
Prospective Randomized Trial of Four Three‐Drug Regimens in the Treatment of DisseminatedMycobacterium aviumComplex Disease in AIDS Patients: Excess Mortality Associated with High‐Dose Clarithromycin
inferredcites →https://doi.org/10.1086/521246openalex-snapshot
Fatal Outbreak of Human Toxoplasmosis along the Maroni River: Epidemiological, Clinical, and Parasitological Aspects
inferredcites →https://doi.org/10.1086/590149openalex-snapshot
Clinical Practice: Management of Toxoplasma gondii Infection during Pregnancy
inferredcites →https://doi.org/10.1086/605637openalex-snapshot
Risk Factors, Clinical Features, and Outcomes of Listeriosis in Solid‐Organ Transplant Recipients: A Matched Case‐Control Study
inferredcites →https://doi.org/10.1086/651266openalex-snapshot
Myeloablative Conditioning Predisposes Patients forToxoplasma gondiiReactivation after Allogeneic Stem Cell Transplantation
inferredcites →https://doi.org/10.1089/apc.2005.19.626openalex-snapshot
Cerebral Toxoplasmosis in HIV-Positive Patients in Brazil: Clinical Features and Predictors of Treatment Response in the HAART Era
inferredcites →https://doi.org/10.1093/cid/cir806openalex-snapshot
Risk Factors, Clinical Features, and Outcomes of Toxoplasmosis in Solid-Organ Transplant Recipients: A Matched Case-Control Study
inferredcites →https://doi.org/10.1093/cid/cis234openalex-snapshot
Efficacy of Rapid Treatment Initiation Following Primary Toxoplasma gondii Infection During Pregnancy
inferredcites →https://doi.org/10.1093/cid/cit032openalex-snapshot
CongenitalToxoplasmaInfection: Monthly Prenatal Screening Decreases Transmission Rate and Improves Clinical Outcome at Age 3 Years
inferredcites →https://doi.org/10.1093/cid/ciu721openalex-snapshot
Intervention Strategies to Reduce Human Toxoplasma gondii Disease Burden
inferredcites →https://doi.org/10.1093/cid/ciw330openalex-snapshot
Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers
inferredcites →https://doi.org/10.1093/clinids/17.supplement_2.s423openalex-snapshot
Toxoplasmosis in Patients with Cancer
inferredcites →https://doi.org/10.1093/clinids/18.1.38openalex-snapshot
Early and Longitudinal Evaluations of Treated Infants and Children and Untreated Historical Patients with Congenital Toxoplasmosis: The Chicago Collaborative Treatment Trial
inferredcites →https://doi.org/10.1093/clinids/22.2.268openalex-snapshot
Pyrimethamine-Clindamycin vs. Pyrimethamine-Sulfadiazine as Acute and Long-Term Therapy for Toxoplasmic Encephalitis in Patients with AIDS
inferredcites →https://doi.org/10.1093/clinids/23.5.1055openalex-snapshot
Congenital Toxoplasmosis Transmitted from an Immunologically Competent Mother Infected Before Conception
inferredcites →https://doi.org/10.1093/clinids/24.3.422openalex-snapshot
Atovaquone for Salvage Treatment and Suppression of Toxoplasmic Encephalitis in Patients with AIDS
inferredcites →https://doi.org/10.1093/ije/30.6.1303openalex-snapshot
Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France
inferredcites →https://doi.org/10.1093/ije/30.6.1309openalex-snapshot
Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis
inferredcites →https://doi.org/10.1093/infdis/155.3.550openalex-snapshot
Murine Model of Intracerebral Toxoplasmosis
inferredcites →https://doi.org/10.1093/infdis/157.1.14openalex-snapshot
In Vitro Assessment of Antimicrobial Agents Against Toxoplasma gondii
inferredcites →https://doi.org/10.1093/infdis/167.2.494openalex-snapshot
The Activity of Atovaquone (566C80) in Murine Toxoplasmosis Is Markedly Augmented when Used in Combination with Pyrimethamine or Sulfadiazine
inferredcites →https://doi.org/10.1093/infdis/170.3.653openalex-snapshot
Experimental Evaluation Of Combined Prophylaxis Against Murine Pneumocystosis And Toxoplasmosis
inferredcites →https://doi.org/10.1093/infdis/jiv235openalex-snapshot
Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons—San Francisco, 1981–2012
inferredcites →https://doi.org/10.1093/jac/dkf251openalex-snapshot
Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii
inferredcites →https://doi.org/10.1093/ndtplus/sfr139openalex-snapshot
Tissue is the issue: a solitary cerebral lesion 15 years after kidney transplantation
inferredcites →https://doi.org/10.1093/ofid/ofv177openalex-snapshot
Get Rich Quick With Old Generic Drugs! The Pyrimethamine Pricing Scandal
inferredcites →https://doi.org/10.1093/ofid/ofw070openalex-snapshot
Toxoplasma Encephalitis in Atypical Hosts at an Academic Cancer Center
inferredcites →https://doi.org/10.1097/00002030-199006000-00003openalex-snapshot
Central nervous system toxoplasmosis in AIDS patients
inferredcites →https://doi.org/10.1097/00002030-200103300-00007openalex-snapshot
Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS
inferredcites →https://doi.org/10.1097/00002030-200406180-00016openalex-snapshot
Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy
inferredcites →https://doi.org/10.1097/00004397-197001030-00007openalex-snapshot
The Treatment of Toxoplasmic Uveitis
inferredcites →https://doi.org/10.1097/00006254-197409000-00007openalex-snapshot
TOXOPLASMOSIS IN PREGNANCY AND ITS TRANSMISSION TO THE FETUS
inferredcites →https://doi.org/10.1097/00007890-198605000-00012openalex-snapshot
THE EFFECTS OF VYCLOSPORINE ON TOXOPLASMA GONDII IN VIVO AN IN VITRO
inferredcites →https://doi.org/10.1097/01.tp.0000188183.49025.d5openalex-snapshot
First Case of Toxoplasmosis Following Small Bowel Transplantation and Systematic Review of Tissue-Invasive Toxoplasmosis Following Noncardiac Solid Organ Transplantation
inferredcites →https://doi.org/10.1097/iae.0b013e31804b3f0dopenalex-snapshot
INTRAVITREAL CLINDAMYCIN FOR TOXOPLASMIC RETINOCHOROIDITIS
inferredcites →https://doi.org/10.1097/inf.0000000000001120openalex-snapshot
Treatment of Congenital Toxoplasmosis
inferredcites →https://doi.org/10.1097/inf.0b013e318134286dopenalex-snapshot
Risk Factors for Retinochoroiditis During the First 2 Years of Life in Infants With Treated Congenital Toxoplasmosis
inferredcites →https://doi.org/10.1097/inf.0b013e3182343096openalex-snapshot
Severe Congenital Toxoplasmosis in the United States
inferredcites →https://doi.org/10.1097/qco.0000000000000169openalex-snapshot
Toxoplasma prophylaxis in haematopoietic cell transplant recipients
inferredcites →https://doi.org/10.1099/00222615-46-3-263openalex-snapshot
A mouse model of recrudescence of Toxoplasma gondii infection
inferredcites →https://doi.org/10.1111/acps.12423openalex-snapshot
Beyond the association. T oxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta‐analysis
inferredcites →https://doi.org/10.1111/hiv.12402openalex-snapshot
A systematic review and meta‐analysis of the relative efficacy and safety of treatment regimens for HIV ‐associated cerebral toxoplasmosis: is trimethoprim‐sulfamethoxazole a real option?
inferredcites →https://doi.org/10.1111/j.0954-6820.1951.tb17165.xopenalex-snapshot
Toxoplasmosis due to Laboratory Infection in Two Adults
inferredcites →https://doi.org/10.1111/j.1442-9071.2005.01061.xopenalex-snapshot
Ocular toxoplasmosis in pregnancy
inferredcites →https://doi.org/10.1111/j.1469-0691.2006.01459.xopenalex-snapshot
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy
inferredcites →https://doi.org/10.1111/j.1469-0691.2008.02091.xopenalex-snapshot
Prevention of toxoplasmosis in transplant patients
inferredcites →https://doi.org/10.1111/j.1469-0691.2011.03648.xopenalex-snapshot
Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana
inferredcites →https://doi.org/10.1111/j.1471-0528.2004.00302.xopenalex-snapshot
Reactivation of ocular toxoplasmosis during pregnancy
inferredcites →https://doi.org/10.1111/j.1476-5381.1957.tb00118.xopenalex-snapshot
THE TREATMENT OF EXPERIMENTAL TOXOPLASMOSIS IN RABBITS
inferredcites →https://doi.org/10.1111/j.1476-5381.1957.tb00119.xopenalex-snapshot
SULPHADIMIDINE, PYRIMETHAMINE AND DAPSONE IN THE TREATMENT OF TOXOPLASMOSIS IN MICE
inferredcites →https://doi.org/10.1111/j.1476-5381.1983.tb10537.xopenalex-snapshot
Comparative effects of cotrimoxazole (trimethoprim‐sulphamethoxazole),pyrimethamine‐sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice
inferredcites →https://doi.org/10.1111/j.1550-7408.2006.00217.xopenalex-snapshot
Prevention of Recrudescent Toxoplasmic Encephalitis using Ponazuril in an Immunodeficient Mouse Model
inferredcites →https://doi.org/10.1111/j.1600-065x.2010.00992.xopenalex-snapshot
Immunology of Toxoplasma gondii
inferredcites →https://doi.org/10.1111/j.1600-0897.1998.tb00527.xopenalex-snapshot
Congenital Toxoplasmosis: Efficacy of Maternal Treatment with Spiramycin Alone
inferredcites →https://doi.org/10.1111/j.1749-6632.1956.tb36617.xopenalex-snapshot
NEWER KNOWLEDGE OF THE CHEMOTHERAPY OF TOXOPLASMOSIS
inferredcites →https://doi.org/10.1111/tri.12853openalex-snapshot
Late isolated ocular toxoplasmosis in a belatacept-treated kidney transplant patient
inferredcites →https://doi.org/10.1128/aac.00502-09openalex-snapshot
Artemisone and Artemiside Control Acute and Reactivated Toxoplasmosis in a Murine Model
inferredcites →https://doi.org/10.1128/aac.01176-16openalex-snapshot
Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity
inferredcites →https://doi.org/10.1128/aac.01683-15openalex-snapshot
Guanabenz Repurposed as an Antiparasitic with Activity against Acute and Latent Toxoplasmosis
inferredcites →https://doi.org/10.1128/aac.05183-11openalex-snapshot
Significant Reduction of Brain Cysts Caused by Toxoplasma gondii after Treatment with Spiramycin Coadministered with Metronidazole in a Mouse Model of Chronic Toxoplasmosis
inferredcites →https://doi.org/10.1128/aac.26.1.26openalex-snapshot
New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A
inferredcites →https://doi.org/10.1128/aac.34.8.1467openalex-snapshot
In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice
inferredcites →https://doi.org/10.1128/aac.35.10.2049openalex-snapshot
Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS
inferredcites →https://doi.org/10.1128/aac.35.2.252openalex-snapshot
Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine
inferredcites →https://doi.org/10.1128/aac.35.2.293openalex-snapshot
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii
inferredcites →https://doi.org/10.1128/aac.35.8.1672openalex-snapshot
Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis
inferredcites →https://doi.org/10.1128/aac.36.2.326openalex-snapshot
In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii
inferredcites →https://doi.org/10.1128/aac.37.11.2371openalex-snapshot
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii
inferredcites →https://doi.org/10.1128/aac.38.9.1930openalex-snapshot
Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeys
inferredcites →https://doi.org/10.1128/aac.39.1.137openalex-snapshot
Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine
inferredcites →https://doi.org/10.1128/aac.40.6.1352openalex-snapshot
Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats
inferredcites →https://doi.org/10.1128/aac.40.9.2067openalex-snapshot
Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model
inferredcites →https://doi.org/10.1128/aac.42.5.1068openalex-snapshot
Drug Evaluation of Concurrent Pneumocystis carinii , Toxoplasma gondii , and Mycobacterium avium Complex Infections in a Rat Model
inferredcites →https://doi.org/10.1128/aac.42.6.1346openalex-snapshot
Randomized Trial of Trimethoprim-Sulfamethoxazole versus Pyrimethamine-Sulfadiazine for Therapy of Toxoplasmic Encephalitis in Patients with AIDS
inferredcites →https://doi.org/10.1128/aac.43.9.2240openalex-snapshot
Synergistic Effect of Clindamycin and Atovaquone in Acute Murine Toxoplasmosis
inferredcites →https://doi.org/10.1128/aac.45.6.1771-1779.2001openalex-snapshot
Atovaquone Nanosuspensions Show Excellent Therapeutic Effect in a New Murine Model of Reactivated Toxoplasmosis
inferredcites →https://doi.org/10.1128/aac.48.12.4848-4854.2004openalex-snapshot
Atovaquone Maintenance Therapy Prevents Reactivation of Toxoplasmic Encephalitis in a Murine Model of Reactivated Toxoplasmosis
inferredcites →https://doi.org/10.1128/aac.5.6.647openalex-snapshot
Effect of Clindamycin on Acute and Chronic Toxoplasmosis in Mice
inferredcites →https://doi.org/10.1128/cmr.11.4.569openalex-snapshot
Regulation and Function of T-Cell-Mediated Immunity duringToxoplasma gondiiInfection
inferredcites →https://doi.org/10.1128/iai.58.9.3050-3055.1990openalex-snapshot
Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon
inferredcites →https://doi.org/10.1128/iai.62.5.1639-1642.1994openalex-snapshot
Interleukin-12 enhances murine survival against acute toxoplasmosis
inferredcites →https://doi.org/10.1128/jcm.01663-15openalex-snapshot
Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States
showing the first 200 of 257 · page through all 257
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4577525openalex-extracted
Single and Combination Treatment of Toxoplasma Gondii Infections with a Bumped Kinase Inhibitor and Artemisone in Vitro and with Artemiside in Experimentally Infected Mice
inferred← citeshttps://doi.org/10.2139/ssrn.4812979openalex-extracted
Toxoplasma Gondii Infection Supports the Infiltration of T Cells into Brain Tumors
inferred← citeshttps://doi.org/10.1002/9781394188741.ch23openalex-snapshot
Recent Trends in Toxoplasmosis Diagnosis and Management
inferred← citeshttps://doi.org/10.1002/9781683670438.cmph0150openalex-snapshot
Serologic Testing for Toxoplasmosis
inferred← citeshttps://doi.org/10.1002/cbic.202000174openalex-snapshot
Coumarin‐Tagged Dinuclear Trithiolato‐Bridged Ruthenium(II)⋅Arene Complexes: Photophysical Properties and Antiparasitic Activity
inferred← citeshttps://doi.org/10.1002/ccr3.4045openalex-snapshot
Treatment of toxoplasmic encephalitis with the combination of clindamycin plus azithromycin in an HIV‐infected patient: A case report
inferred← citeshttps://doi.org/10.1002/cmdc.202500440openalex-snapshot
Structure‐Based Drug Design of Novel Heterocyclic Scaffolds as TgCDPK1 Inhibitors
inferred← citeshttps://doi.org/10.1002/ddr.70334openalex-snapshot
Identification of Quinoline Tethered Thiadiazole/Thiazole Derivatives as Potent Tyrosinase Inhibitors With Promising Anti‐ Toxoplasma gondii Agents: Design, Synthesis, and Computational Analysis
inferred← citeshttps://doi.org/10.1002/fsn3.2021openalex-snapshot
In vitro and in vivo Anti‐Toxoplasma activity of Dracocephalum kotschyi essential oil
inferred← citeshttps://doi.org/10.1002/fsn3.4043openalex-snapshot
Anti‐ Toxoplasma gondii activity of rose hip oil–solid lipid nanoparticles
inferred← citeshttps://doi.org/10.1002/jobm.202400039openalex-snapshot
Linalool‐zinc oxide nanocomposite controls Toxoplasma gondii infection through inhibiting inflammation, oxidative stress, and pathogenicity
inferred← citeshttps://doi.org/10.1002/mco2.70195openalex-snapshot
Organoid‐Guided Precision Medicine: From Bench to Bedside
inferred← citeshttps://doi.org/10.1002/pd.5758openalex-snapshot
Congenital toxoplasmosis: What is the evidence for chemoprophylaxis to prevent fetal infection?
inferred← citeshttps://doi.org/10.1002/slct.202402195openalex-snapshot
Therapeutic Potential of Aryl Sulfonamides: Synthesis, Antiproliferative, Antioxidant, Antiparasitic and Molecular Docking Studies
inferred← citeshttps://doi.org/10.1002/slct.202500410openalex-snapshot
Solution‐Phase and Mechanochemical Synthesis and Antimicrobial Activity of New Thiazolo[3,2‐ a ]Pyridine‐6‐Sulfonamides
inferred← citeshttps://doi.org/10.1002/vms3.71189openalex-snapshot
Rpf‐Toxo: A Preliminary Computationally Designed Dense Granule Antigen‐Based Multi‐Epitope Vaccine Against Toxoplasma gondii
inferred← citeshttps://doi.org/10.1007/7355_2021_142openalex-snapshot
Treatment of Toxoplasmosis: An Insight on Epigenetic Drugs
inferred← citeshttps://doi.org/10.1007/978-3-030-01751-4_51-1openalex-snapshot
Toxoplasma gondii in Solid Organ and Stem Cell Transplant: Prevention and Treatment
inferred← citeshttps://doi.org/10.1007/978-3-030-25869-6_51openalex-snapshot
Toxoplasma gondii in Solid Organ and Stem Cell Transplant: Prevention and Treatment
inferred← citeshttps://doi.org/10.1007/978-3-030-51709-0_14openalex-snapshot
The Treatment of Bacterial and Parasitic Diseases of the Liver
inferred← citeshttps://doi.org/10.1007/978-3-030-93997-7_69openalex-snapshot
Pneumonia in the Newborn Infant
inferred← citeshttps://doi.org/10.1007/978-3-030-99476-1_14openalex-snapshot
Anti-Toxoplasma Effect of Essential Oils Used as Food Ingredient
inferred← citeshttps://doi.org/10.1007/978-3-030-99712-0_7openalex-snapshot
Toxoplasmosis in South America
inferred← citeshttps://doi.org/10.1007/978-3-031-32118-4_3openalex-snapshot
Solid Swellings of the Anterior Triangle: Cervical Lymphadenopathy
inferred← citeshttps://doi.org/10.1007/978-3-031-38495-0_25openalex-snapshot
Meningoencephalitis in Children and Hearing Loss
inferred← citeshttps://doi.org/10.1007/978-3-031-62558-9_11openalex-snapshot
Toxoplasma gondii and Its Relation to Cancer
inferred← citeshttps://doi.org/10.1007/978-3-031-70591-5_9openalex-snapshot
Toxoplasma gondii’s Endosymbionts: An Insight into Their Genomic Secrets
inferred← citeshttps://doi.org/10.1007/978-981-19-7963-7_12openalex-snapshot
Nanomaterials in Animal Nutrition and Disease Treatment: Recent Developments and Future Aspects
inferred← citeshttps://doi.org/10.1007/978-981-19-8225-5_4openalex-snapshot
Cognitive Impairment in Parasitic Protozoan Infection
inferred← citeshttps://doi.org/10.1007/978-981-19-9605-4_15openalex-snapshot
Recent Approaches to Combat Toxoplasma Gondii with Plant-Derived Alternatives
inferred← citeshttps://doi.org/10.1007/s00011-025-02065-wopenalex-snapshot
Annexin A1 is crucial during Toxoplasma gondii infection promoting the modulation of inflammation and intestinal and central nervous system barrier functions
inferred← citeshttps://doi.org/10.1007/s00210-026-05555-8openalex-snapshot
Pharmacological assessment of drugs retained in the 1st and 24th WHO Essential Medicines List (1977–2025)
inferred← citeshttps://doi.org/10.1007/s00347-025-02375-8openalex-snapshot
Okuläre Toxoplasmose im Erwachsenenalter
inferred← citeshttps://doi.org/10.1007/s00436-019-06493-6openalex-snapshot
Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites
inferred← citeshttps://doi.org/10.1007/s00436-020-06766-5openalex-snapshot
Treatment with melatonin induces a reduction of Toxoplasma gondii development in LLC-MK2 cells
inferred← citeshttps://doi.org/10.1007/s00436-020-06815-zopenalex-snapshot
Effect of deletion of gra17 and gra23 genes on the growth, virulence, and immunogenicity of type II Toxoplasma gondii
inferred← citeshttps://doi.org/10.1007/s00436-023-07968-3openalex-snapshot
Phytohormones regulate asexual Toxoplasma gondii replication
inferred← citeshttps://doi.org/10.1007/s00436-023-08038-4openalex-snapshot
The Brazilian Toxoplasma gondii strain BRI caused greater inflammation and impairment in anxiogenic behavior in mice, which was reverted by rosuvastatin treatment
inferred← citeshttps://doi.org/10.1007/s00436-024-08133-0openalex-snapshot
Therapeutic potential of antimicrobial peptides against pathogenic protozoa
inferred← citeshttps://doi.org/10.1007/s00436-024-08231-zopenalex-snapshot
Essential oil of oregano (Origanum vulgare L.) reduces infection and proliferation of Toxoplasma gondii in BeWo cells with induction of autophagy and death of tachyzoites through a mechanism similar to necrosis
inferred← citeshttps://doi.org/10.1007/s00436-026-08646-wopenalex-snapshot
Anti-Toxoplasma activity of NBMPR is mediated through the inhibition of nucleoside and nucleobase transporters
inferred← citeshttps://doi.org/10.1007/s00436-026-08724-zopenalex-snapshot
Quinolones as anti-Toxoplasma agents: a comprehensive scoping review of in vitro and in vivo efficacy
inferred← citeshttps://doi.org/10.1007/s11033-022-07327-yopenalex-snapshot
TNFα rs1799964 TT genotype may be a susceptibility factor for vertical transmission of Toxoplasma gondii and clinical signs in newborns from pregnant women with acute toxoplasmosis
inferred← citeshttps://doi.org/10.1007/s11259-026-11348-4openalex-snapshot
Antiparasitic activity of peppermint and lavender essential oil nano-emulsions against Toxoplasma gondii RH strain in vitro and in vivo
inferred← citeshttps://doi.org/10.1007/s11259-026-11535-3openalex-snapshot
From dysbiosis to disease: the role of gut microbial communities in Toxoplasma gondii pathogenesis, zoonotic transmission, diagnostic innovation, and therapeutic outcomes
inferred← citeshttps://doi.org/10.1007/s11686-023-00759-xopenalex-snapshot
Anti-Toxoplasma In Vitro and In Vivo Activity of Pyrus boissieriana Arbutin-Rich Fraction
inferred← citeshttps://doi.org/10.1007/s11686-024-00845-8openalex-snapshot
High Efficacy of Green Synthesized Silver Nanoparticles for Treatment of Toxoplasma Gondii Infection Through Their Immunomodulatory, Anti-Inflammatory, and Antioxidant Potency
inferred← citeshttps://doi.org/10.1007/s11686-024-00875-2openalex-snapshot
Investigation of Toxoplasma gondii Infection in Yunnan Semi-fine Wool Sheep (Ovis aries) and wild Rodents in Yunnan, China
inferred← citeshttps://doi.org/10.1007/s11686-024-00884-1openalex-snapshot
Zingiber officinale Ameliorates Acute Toxoplasmosis-Induced Pathology in Mice
inferred← citeshttps://doi.org/10.1007/s11686-025-01093-0openalex-snapshot
Potential Therapeutic Effects of Isopropyltoluene (P-Cymene) Against Toxoplasma gondii Infection in Dexamethasone-Immunosuppressed Mice
inferred← citeshttps://doi.org/10.1007/s11686-026-01329-7openalex-snapshot
The Effect of Curcumin on Chronic Toxoplasma gondii Infection in the Testes of BALB/c Mice
inferred← citeshttps://doi.org/10.1007/s12639-020-01262-0openalex-snapshot
Diagnostic significance of C-reactive protein and hematological parameters in acute toxoplasmosis
inferred← citeshttps://doi.org/10.1007/s12639-022-01514-1openalex-snapshot
Potential effects of alpha-pinene, a monoterpene commonly found in essential oils against Toxoplasma gondii infection; an in vitro and in vivo study
inferred← citeshttps://doi.org/10.1007/s12639-023-01603-9openalex-snapshot
The effects of intracellular iron availability on the outcome of Toxoplasma gondii infection in mice
inferred← citeshttps://doi.org/10.1007/s12639-023-01642-2openalex-snapshot
Comparative evaluation of silver nanoparticles and human platelet rich-plasma versus traditional therapy in the treatment of murine chronic toxoplasmosis
inferred← citeshttps://doi.org/10.1007/s12639-024-01664-4openalex-snapshot
Toxoplasmosis in animals and humans: a neglected zoonotic disease in Bangladesh
inferred← citeshttps://doi.org/10.1007/s12639-025-01786-3openalex-snapshot
Evaluation of anti-Toxoplasma effects of lipid nanoparticles carrying tea tree oil on Toxoplasma gondii tachyzoites in Vero cells
inferred← citeshttps://doi.org/10.1007/s12639-025-01862-8openalex-snapshot
The efficacy of resveratrol and nitazoxanide combination therapy in a murine model of chronic toxoplasmosis
inferred← citeshttps://doi.org/10.1007/s12639-026-01928-1openalex-snapshot
Zoonotic protozoan diseases across species: recent insights into toxoplasmosis, balantidiasis, and babesiosis
inferred← citeshttps://doi.org/10.1007/s13312-024-3214-0openalex-snapshot
Zoonoses Presenting as Head and Neck Swellings
inferred← citeshttps://doi.org/10.1007/s40203-023-00140-wopenalex-snapshot
In silico design of a novel peptide-based vaccine against the ubiquitous apicomplexan Toxoplasma gondii using surface antigens
inferred← citeshttps://doi.org/10.1016/b978-0-12-815041-2.00005-0openalex-snapshot
Ocular disease due to Toxoplasma gondii
inferred← citeshttps://doi.org/10.1016/b978-0-12-815041-2.00007-4openalex-snapshot
Toxoplasma animal models and therapeutics
inferred← citeshttps://doi.org/10.1016/b978-0-12-815041-2.00011-6openalex-snapshot
The apicoplast and mitochondrion of Toxoplasma gondii
inferred← citeshttps://doi.org/10.1016/b978-0-12-818731-9.00096-3openalex-snapshot
Anti-Parasite Agents and Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-323-90792-7.00010-5openalex-snapshot
Nano-targeted drug delivery for parasitic infections
inferred← citeshttps://doi.org/10.1016/b978-0-323-99967-0.00132-0openalex-snapshot
Protozoan Diseases: Toxoplasmosis
inferred← citeshttps://doi.org/10.1016/bs.apha.2024.05.001openalex-snapshot
Discovery of novel anti-infective agents
inferred← citeshttps://doi.org/10.1016/bs.enz.2025.05.004openalex-snapshot
Toxoplasma gondii, babesia, and other protozoan carbonic anhydrases
inferred← citeshttps://doi.org/10.1016/j.actatropica.2022.106332openalex-snapshot
Parasites causing cutaneous wounds: Theory and practice from a dermatological point of view
inferred← citeshttps://doi.org/10.1016/j.actatropica.2022.106432openalex-snapshot
Toxoplasmosis in Human and Animals Around the World. Diagnosis and Perspectives in the One Health Approach
inferred← citeshttps://doi.org/10.1016/j.actatropica.2022.106722openalex-snapshot
Comprehensive analysis of mRNA-lncRNA co-expression profiles in mouse brain during infection with Toxoplasma gondii
inferred← citeshttps://doi.org/10.1016/j.actatropica.2022.106797openalex-snapshot
Microenvironment pH modified solid dispersion of Toltrazuril as a new strategy to improve the treatment of experimental Apicomplexan infection
inferred← citeshttps://doi.org/10.1016/j.actatropica.2023.106830openalex-snapshot
The effects of L-citrulline adjunctive treatment of Toxoplasma gondii RH strain infection in a mouse model
inferred← citeshttps://doi.org/10.1016/j.actatropica.2023.107011openalex-snapshot
New Allele-Specific Oligonucleotide (ASO) amplifications for Toxoplasma gondii rop18 allele typing: Analysis of 86 human congenital infections in Brazil
inferred← citeshttps://doi.org/10.1016/j.actatropica.2023.107041openalex-snapshot
Protective efficacy of Toxoplasma gondii infected cells-derived exosomes against chronic murine toxoplasmosis
inferred← citeshttps://doi.org/10.1016/j.actatropica.2024.107211openalex-snapshot
The impact of miRNA-155 in acute and chronic toxoplasmosis in Iraqi women
inferred← citeshttps://doi.org/10.1016/j.actatropica.2025.107576openalex-snapshot
Assessing the therapeutic potential of silicon dioxide nanoparticles in acute and chronic toxoplasmosis in BALB/c mice
inferred← citeshttps://doi.org/10.1016/j.amjmed.2021.12.005openalex-snapshot
`Concentric and Eccentric` Target Signs in Cerebral Toxoplasmosis
inferred← citeshttps://doi.org/10.1016/j.azn.2026.05.002openalex-snapshot
Zoonotic parasites: Definitions, exposure categories, and integrated control
inferred← citeshttps://doi.org/10.1016/j.bbih.2020.100128openalex-snapshot
Urolithin-A attenuates neurotoxoplasmosis and alters innate response towards predator odor
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113811openalex-snapshot
Novel insights on the potential activity of propolis and wheat germ oil against chronic toxoplasmosis in experimentally infected mice
inferred← citeshttps://doi.org/10.1016/j.biopha.2025.117956openalex-snapshot
Chemotherapy against Toxoplasma gondii: A bibliometric analysis of in vitro and mouse model studies (2015–2024)
inferred← citeshttps://doi.org/10.1016/j.bmc.2021.116467openalex-snapshot
In vitro activity of N-phenyl-1,10-phenanthroline-2-amines against tachyzoites and bradyzoites of Toxoplasma gondii
inferred← citeshttps://doi.org/10.1016/j.bse.2024.104891openalex-snapshot
Pharmacological insights into Laurus nobilis: HPLC profiling and evaluation of its anti-Toxoplasma, antioxidant, and anti-hemolytic properties
inferred← citeshttps://doi.org/10.1016/j.cbi.2021.109676openalex-snapshot
The anti-parasite action of imidazole derivatives likely involves oxidative stress but not HIF-1α signaling
inferred← citeshttps://doi.org/10.1016/j.cclet.2023.108359openalex-snapshot
Recent research progress on small molecule compounds and its derivatives of antiparasitic drugs
inferred← citeshttps://doi.org/10.1016/j.cmi.2020.10.009openalex-snapshot
Toxoplasmosis after allogeneic haematopoietic cell transplantation—disease burden and approaches to diagnosis, prevention and management in adults and children
inferred← citeshttps://doi.org/10.1016/j.crpvbd.2026.100412openalex-snapshot
Cerebral toxoplasmosis: Parasitology, diagnosis, treatment, and prevention - a narrative review
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2020.115296openalex-snapshot
The activity of the diaminopyrimidine dihydrofolate reducatase inhibitor, iclaprim, against Toxoplasma gondii in an in vitro model: a pilot study
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113610openalex-snapshot
The quest of the best – A SAR study of trithiolato-bridged dinuclear Ruthenium(II)-Arene compounds presenting antiparasitic properties
inferred← citeshttps://doi.org/10.1016/j.ejps.2021.105837openalex-snapshot
Development of a chimeric vaccine candidate based on Toxoplasma gondii major surface antigen 1 and apicoplast proteins using comprehensive immunoinformatics approaches
inferred← citeshttps://doi.org/10.1016/j.exppara.2019.05.003openalex-snapshot
Sex dichotomy in the course of experimental latent toxoplasmosis
inferred← citeshttps://doi.org/10.1016/j.exppara.2023.108655openalex-snapshot
Single and combination treatment of Toxoplasma gondii infections with a bumped kinase inhibitor and artemisone in vitro and with artemiside in experimentally infected mice
inferred← citeshttps://doi.org/10.1016/j.exppara.2024.108771openalex-snapshot
Copaifera spp. oleoresins and two isolated compounds (ent-kaurenoic and ent-polyalthic acid) inhibit Toxoplasma gondii growth in vitro
inferred← citeshttps://doi.org/10.1016/j.exppara.2025.109011openalex-snapshot
Development of an in vitro assay using abscisic acid to study Toxoplasma gondii infectivity
inferred← citeshttps://doi.org/10.1016/j.exppara.2025.109024openalex-snapshot
Niosomes as a vehicle for excretory/secretory antigens enhance immunization efficacy of Toxoplasma gondii vaccine
inferred← citeshttps://doi.org/10.1016/j.exppara.2026.109209openalex-snapshot
Evaluation of tissue cyst protection in pigs immunized by intradermal and intramuscular routes with a DNA vaccine (rop18 + sag1) against Toxoplasma gondii
inferred← citeshttps://doi.org/10.1016/j.fawpar.2019.e00036openalex-snapshot
Treatment of toxoplasmosis: Current options and future perspectives
inferred← citeshttps://doi.org/10.1016/j.fbio.2023.103059openalex-snapshot
The potent synergistic effect of Brassica oleracea against congenital Toxoplasma infection in rat model
inferred← citeshttps://doi.org/10.1016/j.gofs.2021.03.003openalex-snapshot
Toxoplasmose pendant la grossesse : proposition actuelle de prise en charge pratique
inferred← citeshttps://doi.org/10.1016/j.idcr.2025.e02319openalex-snapshot
Secondary adrenal insufficiency in a young man with HIV and pulmonary tuberculosis, complicated by cerebral toxoplasmosis and seizure
inferred← citeshttps://doi.org/10.1016/j.idcr.2025.e02354openalex-snapshot
The global status of toxoplasmic myocarditis: A case series and systematic literature review
inferred← citeshttps://doi.org/10.1016/j.ijpara.2020.11.001openalex-snapshot
Control of human toxoplasmosis
inferred← citeshttps://doi.org/10.1016/j.ijpara.2020.11.006openalex-snapshot
Protein kinases in Toxoplasma gondii
inferred← citeshttps://doi.org/10.1016/j.ijpddr.2022.11.005openalex-snapshot
Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation
inferred← citeshttps://doi.org/10.1016/j.ijpddr.2024.100552openalex-snapshot
In vitro and in vivo activity evaluation and mode of action of broxaldine on Toxoplasma gondii
inferred← citeshttps://doi.org/10.1016/j.ijpddr.2024.100575openalex-snapshot
Lactoferrin-modified nanoemulsions enhance brain-targeting and therapeutic efficacy of arctigenin against Toxoplasma gondii-induced neuronal injury
inferred← citeshttps://doi.org/10.1016/j.ijpddr.2025.100606openalex-snapshot
Screening and hit evaluation of a microbial metabolite library against the pathogenic Plasmodium falciparum and Toxoplasma gondii parasites
inferred← citeshttps://doi.org/10.1016/j.ijpddr.2026.100641openalex-snapshot
Screening of purine nucleoside analogues against intracellular Toxoplasma gondii
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2023.122912openalex-snapshot
Surfactant vesicles for enhanced antitoxoplasmic effect of norfloxacin: In vitro and in vivo evaluations
inferred← citeshttps://doi.org/10.1016/j.ijppaw.2023.09.002openalex-snapshot
Nasal vaccination of six squirrel monkeys (Saimiri sciureus): Improved immunization protocol against Toxoplasma gondii with a nanoparticle-born vaccine
inferred← citeshttps://doi.org/10.1016/j.imbio.2026.153182openalex-snapshot
Blue light-emitting diode phototherapy reduces cerebral parasitic load and inflammation in murine congenital toxoplasmosis model
inferred← citeshttps://doi.org/10.1016/j.isci.2020.101871openalex-snapshot
Target Identification of an Antimalarial Oxaborole Identifies AN13762 as an Alternative Chemotype for Targeting CPSF3 in Apicomplexan Parasites
inferred← citeshttps://doi.org/10.1016/j.isci.2025.114292openalex-snapshot
GSK3β/HIF-1α signaling-dependent anti-parasite effect of Cynanchi atrati Radix
inferred← citeshttps://doi.org/10.1016/j.isci.2025.114415openalex-snapshot
Toxoplasma gondii-induced region-specific disintegration in glutamatergic neurotransmission is linked to cognitive impairments in mice
inferred← citeshttps://doi.org/10.1016/j.jbc.2026.113160openalex-snapshot
Parasite-specific essential bromodomain protein TgBDP4 is a key epigenetic reader and a potential drug target for the parasite Toxoplasma gondii
inferred← citeshttps://doi.org/10.1016/j.jece.2024.115029openalex-snapshot
Ultrathin LDH-coated SnO2 catalysts linked by hydrogen bonding for PMS activation via interlayer high-speed electron transfer channels: Performance and mechanism
inferred← citeshttps://doi.org/10.1016/j.jep.2021.114019openalex-snapshot
Anti-parasitic activity of Annona muricata L. leaf ethanolic extract and its fractions against Toxoplasma gondii in vitro and in vivo
inferred← citeshttps://doi.org/10.1016/j.jfo.2021.11.007openalex-snapshot
Prise en charge de la toxoplasmose oculaire en France : résultats d’une étude Delphi modifiée
inferred← citeshttps://doi.org/10.1016/j.jgar.2025.03.002openalex-snapshot
Therapeutic effects of zinc nanoparticles green synthesized by Ferula macercolea extract against chronic toxoplasmosis in mice
inferred← citeshttps://doi.org/10.1016/j.jhlto.2025.100450openalex-snapshot
Parasitic diseases in heart transplantation: challenges of Toxoplasmosis and Chagas Disease
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2024.578402openalex-snapshot
Toxoplasma gondii infection supports the infiltration of T cells into brain tumors
inferred← citeshttps://doi.org/10.1016/j.jorganchem.2023.122624openalex-snapshot
Trithiolato-bridged dinuclear ruthenium(II)-arene conjugates tethered with lipophilic units: Synthesis and Toxoplasma gondii antiparasitic activity
inferred← citeshttps://doi.org/10.1016/j.jtct.2020.11.003openalex-snapshot
Toxoplasmosis in Pediatric Hematopoietic Stem Cell Transplantation Patients
inferred← citeshttps://doi.org/10.1016/j.lwt.2024.117026openalex-snapshot
Lactobacillus plantarum antimicrobial peptide Y8-2: A new strategy against Toxoplasma gondii
inferred← citeshttps://doi.org/10.1016/j.medidd.2023.100157openalex-snapshot
Potent anti-Toxoplasma gondii activity of 4-chlorophenylthioacetone-derived thiosemicarbazones: Involvement of CCR2 and CCR5 receptors and 5-lipoxygenase in the mode of action
inferred← citeshttps://doi.org/10.1016/j.meegid.2021.105037openalex-snapshot
Insights into the biochemical features and immunogenic epitopes of common bradyzoite markers of the ubiquitous Toxoplasma gondii
inferred← citeshttps://doi.org/10.1016/j.micpath.2021.104888openalex-snapshot
Genetic immunization against toxoplasmosis: A review article
inferred← citeshttps://doi.org/10.1016/j.micpath.2021.105312openalex-snapshot
Co-delivery of PLGA nanoparticles loaded with rSAG1 antigen and TLR ligands: An efficient vaccine against chronic toxoplasmosis
inferred← citeshttps://doi.org/10.1016/j.micpath.2023.106340openalex-snapshot
Assessment of tissue levels of miR-146a and proinflammatory cytokines in experimental cerebral toxoplasmosis following atovaquone and clindamycin treatment: An in vivo study
inferred← citeshttps://doi.org/10.1016/j.micpath.2026.108705openalex-snapshot
Anti-Toxoplasma gondii activity of two novel synthetic compounds based on pyridine, benzimidazole and benzoxazole scaffolds in human maternal-fetal interface models
inferred← citeshttps://doi.org/10.1016/j.molbiopara.2021.111411openalex-snapshot
Rebound of cyst number following discontinuation of guanabenz treatment for latent toxoplasmosis
inferred← citeshttps://doi.org/10.1016/j.parepi.2022.e00279openalex-snapshot
Toxoplasma gondii-associated Placentitis in the absence of maternal seroconversion
inferred← citeshttps://doi.org/10.1016/j.parint.2021.102424openalex-snapshot
Evaluation of Mongolian compound library for potential antimalarial and anti-Toxoplasma agents
inferred← citeshttps://doi.org/10.1016/j.parint.2024.102997openalex-snapshot
Recent advances in identifying and characterizing secretory proteins of Toxoplasma gondii by CRISPR-based screening
inferred← citeshttps://doi.org/10.1016/j.pestbp.2025.106524openalex-snapshot
Toltrazuril inhibits Toxoplasma gondii by potentially targeting pyrimidine metabolism
inferred← citeshttps://doi.org/10.1016/j.phymed.2022.154522openalex-snapshot
Resveratrol inhibits Toxoplasma gondii-induced lung injury, inflammatory cascade and evidences of its mechanism of action
inferred← citeshttps://doi.org/10.1016/j.phymed.2024.155765openalex-snapshot
A novel mechanism of resveratrol alleviates Toxoplasma gondii infection-induced pulmonary inflammation via inhibiting inflammasome activation
inferred← citeshttps://doi.org/10.1016/j.prevetmed.2026.106825openalex-snapshot
Toxoplasma gondii infection in wildlife in China (1985–2024): A systematic review and meta-analysis with machine learning
inferred← citeshttps://doi.org/10.1016/j.pt.2019.01.005openalex-snapshot
Advances in the Development of Anti-Toxoplasma gondii Vaccines: Challenges, Opportunities, and Perspectives
inferred← citeshttps://doi.org/10.1016/j.pt.2019.07.010openalex-snapshot
Delayed Death by Plastid Inhibition in Apicomplexan Parasites
inferred← citeshttps://doi.org/10.1016/j.pt.2020.08.005openalex-snapshot
Toxoplasma gondii: An Underestimated Threat?
inferred← citeshttps://doi.org/10.1016/j.pt.2022.09.004openalex-snapshot
Targeting malaria parasites inside mosquitoes: ecoevolutionary consequences
inferred← citeshttps://doi.org/10.1016/j.pt.2022.09.008openalex-snapshot
The mystery of massive mitochondrial complexes: the apicomplexan respiratory chain
inferred← citeshttps://doi.org/10.1016/j.retram.2024.103475openalex-snapshot
In silico analysis and structural vaccinology prediction of Toxoplasma gondii ROP41 gene via immunoinformatics methods as a vaccine candidate
inferred← citeshttps://doi.org/10.1016/j.rvsc.2020.10.019openalex-snapshot
Foodborne transmission of Toxoplasma gondii infection in the last decade. An overview
inferred← citeshttps://doi.org/10.1016/j.snb.2025.137960openalex-snapshot
Sample-to-answer Aggregation-Induced Emission Lateral Flow Immunoassay (ALFIA) for rapid and sensitive on-site detection of Toxoplasma gondii antibodies across multiple host species
inferred← citeshttps://doi.org/10.1016/j.tice.2024.102533openalex-snapshot
Mastocytosis and intraepithelial lymphocytosis in the ileum and colon characterize chronic Toxoplasma gondii infection in mice
inferred← citeshttps://doi.org/10.1016/j.toxicon.2025.108540openalex-snapshot
Anti-Toxoplasma gondii studies of the venom peptide XYP4 from the Lycosa coelestis
inferred← citeshttps://doi.org/10.1016/j.vaccine.2019.05.083openalex-snapshot
Vaccination challenges and strategies against long-lived Toxoplasma gondii
inferred← citeshttps://doi.org/10.1016/j.vaccine.2020.12.072openalex-snapshot
Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infection
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.02.062openalex-snapshot
Protective efficacy of recombinant Toxoplasma gondii dense granule protein 15 against toxoplasmosis in C57BL/6 mice
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.06.032openalex-snapshot
A novel DNA vaccine encoding the SRS13 protein administered by electroporation confers protection against chronic toxoplasmosis
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.126632openalex-snapshot
Evaluation of the toxoplasma Urm1 gene deletion mutant (PruΔUrm1) as a promising vaccine candidate against toxoplasmosis in mice
inferred← citeshttps://doi.org/10.1016/j.vaccine.2026.128554openalex-snapshot
Heterologous DNA prime–crude tachyzoite lysate antigen boost targeting MIC8 confers protection against acute and chronic Toxoplasma gondii infection in mice
inferred← citeshttps://doi.org/10.1016/j.vaccine.2026.128785openalex-snapshot
Design and synthesis of RNA vaccines encoding SAG1 antigen of toxoplasma gondii and evaluation of immunogenicity and its protective efficacy against acute toxoplasmosis in BALB/c mice
inferred← citeshttps://doi.org/10.1016/s1166-8598(20)42877-7openalex-snapshot
10.1016/s1166-8598(20)42877-7
inferred← citeshttps://doi.org/10.1017/s0031182022000427openalex-snapshot
Targeting HDACs of apicomplexans: structural insights for a better treatment
inferred← citeshttps://doi.org/10.1021/acs.cgd.1c00005openalex-snapshot
Polymorphic Cocrystals of the Antimalarial Drug Pyrimethamine: Two Case Studies
inferred← citeshttps://doi.org/10.1021/acs.jced.1c00672openalex-snapshot
Solubility Measurement and Data Correlation of Pyrimethamine in 13 Pure Solvents at Temperatures from 278.15 to 318.15 K
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00419openalex-snapshot
Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c01569openalex-snapshot
Chemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure–Activity Relationship Investigations
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c01733openalex-snapshot
Comprehensive Insights into the Development of Antitoxoplasmosis Drugs: Current Advances, Obstacles, and Future Perspectives
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c00865openalex-snapshot
Improved Bicyclic Pyrrolidine Analogues Inhibit Toxoplasma gondii Growth In Vitro and Cure Infection In Vivo
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6c00065openalex-snapshot
Lead Optimization of TgCDPK1 Inhibitors for the Treatment of Toxoplasmosis
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.2c01027openalex-snapshot
Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal–Drug Synergism in Metallodrug Design
inferred← citeshttps://doi.org/10.1021/acsinfecdis.4c00170openalex-snapshot
Bicyclic Pyrrolidine Inhibitors of Toxoplasma gondii Phenylalanine t-RNA Synthetase with Antiparasitic Potency In Vitro and Brain Exposure
inferred← citeshttps://doi.org/10.1021/acsinfecdis.5c00609openalex-snapshot
Activity of Antibacterial/Antifungal Compounds against the Protozoan Parasite, Toxoplasma gondii
inferred← citeshttps://doi.org/10.1021/acsinfecdis.5c01074openalex-snapshot
Legacy 4(1 H )-Quinolone Scaffolds Activity against Acute and Chronic Toxoplasma gondii Infection
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.0c00267openalex-snapshot
Dual-Stage Picolinic Acid-Derived Inhibitors of Toxoplasma gondii
inferred← citeshttps://doi.org/10.1021/acsomega.5c00640openalex-snapshot
Computational Structural Comparison of Toxoplasma gondii CDPK1 and Human BUB1 kinases: Implications for Selective Inhibitor Design
inferred← citeshttps://doi.org/10.1021/acsomega.6c05944openalex-snapshot
4- O -Allyl Derivative of Natural Licarin A Exhibits Selective In Vitro Activity against Toxoplasma gondii Tachyzoites
inferred← citeshttps://doi.org/10.1038/s41467-021-23351-1openalex-snapshot
Cryo-EM structure of cortical microtubules from human parasite Toxoplasma gondii identifies their microtubule inner proteins
inferred← citeshttps://doi.org/10.1038/s41467-022-28108-yopenalex-snapshot
Bicyclic azetidines target acute and chronic stages of Toxoplasma gondii by inhibiting parasite phenylalanyl t-RNA synthetase
inferred← citeshttps://doi.org/10.1038/s41467-022-28730-wopenalex-snapshot
In vitro maturation of Toxoplasma gondii bradyzoites in human myotubes and their metabolomic characterization
inferred← citeshttps://doi.org/10.1038/s41467-025-64701-7openalex-snapshot
Structural and functional characterization of TgGSK3, a druggable kinase in Toxoplasma gondii
inferred← citeshttps://doi.org/10.1038/s41467-026-71902-1openalex-snapshot
Evolutionary remodeling of ubiquinone biosynthesis in Toxoplasma gondii reveals an essential bi-functional monooxygenase
inferred← citeshttps://doi.org/10.1038/s41541-022-00563-0openalex-snapshot
Toxoplasmosis vaccines: what we have and where to go?
inferred← citeshttps://doi.org/10.1038/s41541-024-00996-9openalex-snapshot
Toxoplasma WH3 Δrop18 acts as a live attenuated vaccine against acute and chronic toxoplasmosis
inferred← citeshttps://doi.org/10.1038/s41564-022-01249-yopenalex-snapshot
CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery
inferred← citeshttps://doi.org/10.1038/s41579-019-0238-xopenalex-snapshot
Protozoan persister-like cells and drug treatment failure
inferred← citeshttps://doi.org/10.1038/s41579-021-00518-7openalex-snapshot
Toxoplasma gondii infection and its implications within the central nervous system
inferred← citeshttps://doi.org/10.1038/s41598-020-80569-7openalex-snapshot
Adverse outcomes associated with the treatment of Toxoplasma infections
inferred← citeshttps://doi.org/10.1038/s41598-023-32388-9openalex-snapshot
Computational screening of FDA-approved drugs to identify potential TgDHFR, TgPRS, and TgCDPK1 proteins inhibitors against Toxoplasma gondii
showing the first 200 of 554 · page through all 554
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.